Startup data
| Business model | |
|---|---|
| Country | |
| Investment Received | |
| Revenues | |
| Scope | |
| Startup stage | |
| Tecnhologies | |
| Verticals |
NIB biotec
€0,00
Video-Pitch: https://vimeo.com/801311312
Description: NIB biotec own a patent that claims the use of urinary molecules as biomarkers for prostate cancer, with better diagnostic performance compared to the current standard of care. We developed the MVP of ScreeNIB test, a smart biosensor that can rapidly provide to the urologist information about the presence of prostate cancer at low-cost and and at the patient site in order to simplify diagnostic pathways, minimize steps in hospitals and decentralize the first-line exams outside hospitals and towards the territory.
